On Tuesday, 18 November 2025, InMode Ltd (NASDAQ:INMD) presented at the Jefferies London Healthcare Conference 2025, outlining both achievements and challenges. The company, known for its minimally ...
InMode (INMD) posted a net profit margin of 44.5%, outpacing last year's mark of 35.8%, as annual earnings climbed 19.8%, notably ahead of the company’s 11.8% five-year average. Revenue is forecast to ...
YOKNEAM, Israel (AP) — YOKNEAM, Israel (AP) — InMode Ltd. (INMD) on Wednesday reported net income of $21.9 million in its third quarter. The Yokneam, Israel-based company said it had net income of 34 ...
InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radiofrequency ("RF") technology. InMode strives to enable ...
Investing.com - InMode Ltd. (NASDAQ:INMD), currently trading below InvestingPro’s Fair Value estimate and maintaining a "GREAT" financial health score, announced preliminary third-quarter revenue ...
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. InMode ( (INMD)) just unveiled an ...
YOKNEAM, Israel (AP) — YOKNEAM, Israel (AP) — InMode Ltd. (INMD) on Wednesday reported earnings of $26.7 million in its second quarter. On a per-share basis, the Yokneam, Israel-based company said it ...
Barclays analyst Matt Miksic raised the firm’s price target on InMode (INMD) to $29 from $26 and keeps an Overweight rating on the shares post the Q4 report. The firm says the company delivered ...
Despite INMD being down -22% since I recommended to Buy the stock in March, InMode Ltd. remains a highly profitable & innovative leader in the aesthetic industry. Stronger than expected macroeconomic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results